Insulet Gross Margin 2012-2026 | PODD
Current and historical gross margin for Insulet (PODD) over the last 10 years. The current gross profit margin for Insulet as of March 31, 2026 is %.
| Insulet Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2026-03-31 | $2.90B | $2.06B | 71.01% |
| 2025-12-31 | $2.71B | $1.94B | 71.64% |
| 2025-09-30 | $2.52B | $1.80B | 71.45% |
| 2025-06-30 | $2.36B | $1.67B | 70.72% |
| 2025-03-31 | $2.20B | $1.55B | 70.36% |
| 2024-12-31 | $2.07B | $1.45B | 69.75% |
| 2024-09-30 | $1.99B | $1.38B | 69.32% |
| 2024-06-30 | $1.87B | $1.29B | 68.94% |
| 2024-03-31 | $1.78B | $1.23B | 68.80% |
| 2023-12-31 | $1.70B | $1.16B | 68.32% |
| 2023-09-30 | $1.56B | $1.02B | 65.21% |
| 2023-06-30 | $1.47B | $0.91B | 62.14% |
| 2023-03-31 | $1.37B | $0.84B | 61.11% |
| 2022-12-31 | $1.31B | $0.81B | 61.69% |
| 2022-09-30 | $1.24B | $0.80B | 64.44% |
| 2022-06-30 | $1.18B | $0.80B | 68.08% |
| 2022-03-31 | $1.14B | $0.80B | 69.61% |
| 2021-12-31 | $1.10B | $0.75B | 68.52% |
| 2021-09-30 | $1.04B | $0.70B | 67.60% |
| 2021-06-30 | $1.00B | $0.66B | 66.73% |
| 2021-03-31 | $0.96B | $0.62B | 65.14% |
| 2020-12-31 | $0.90B | $0.58B | 64.49% |
| 2020-09-30 | $0.87B | $0.56B | 64.13% |
| 2020-06-30 | $0.83B | $0.53B | 63.88% |
| 2020-03-31 | $0.78B | $0.50B | 64.43% |
| 2019-12-31 | $0.74B | $0.48B | 65.04% |
| 2019-09-30 | $0.69B | $0.46B | 65.71% |
| 2019-06-30 | $0.65B | $0.44B | 66.62% |
| 2019-03-31 | $0.60B | $0.40B | 66.83% |
| 2018-12-31 | $0.56B | $0.37B | 65.60% |
| 2018-09-30 | $0.53B | $0.34B | 64.15% |
| 2018-06-30 | $0.50B | $0.31B | 62.28% |
| 2018-03-31 | $0.49B | $0.30B | 60.57% |
| 2017-12-31 | $0.47B | $0.28B | 59.78% |
| 2017-09-30 | $0.44B | $0.26B | 59.13% |
| 2017-06-30 | $0.41B | $0.24B | 58.64% |
| 2017-03-31 | $0.39B | $0.23B | 58.25% |
| 2016-12-31 | $0.37B | $0.21B | 57.49% |
| 2016-09-30 | $0.35B | $0.19B | 55.33% |
| 2016-06-30 | $0.32B | $0.17B | 52.01% |
| 2016-03-31 | $0.30B | $0.15B | 50.17% |
| 2015-12-31 | $0.26B | $0.13B | 50.76% |
| 2015-09-30 | $0.20B | $0.11B | 57.95% |
| 2015-06-30 | $0.20B | $0.12B | 59.80% |
| 2015-03-31 | $0.21B | $0.12B | 59.05% |
| 2014-12-31 | $0.23B | $0.13B | 55.41% |
| 2014-09-30 | $0.29B | $0.14B | 49.12% |
| 2014-06-30 | $0.27B | $0.13B | 47.60% |
| 2014-03-31 | $0.26B | $0.12B | 46.33% |
| 2013-12-31 | $0.25B | $0.11B | 45.34% |
| 2013-09-30 | $0.24B | $0.10B | 44.07% |
| 2013-06-30 | $0.23B | $0.10B | 43.91% |
| 2013-03-31 | $0.22B | $0.10B | 43.44% |
| 2012-12-31 | $0.21B | $0.09B | 42.92% |
| 2012-09-30 | $0.20B | $0.09B | 42.79% |
| 2012-06-30 | $0.19B | $0.08B | 42.41% |
| 2012-03-31 | $0.17B | $0.07B | 43.02% |
| 2011-12-31 | $0.15B | $0.07B | 44.74% |
| 2011-09-30 | $0.13B | $0.06B | 46.62% |
| 2011-06-30 | $0.11B | $0.06B | 48.67% |
| 2011-03-31 | $0.10B | $0.05B | 48.08% |
| 2010-12-31 | $0.10B | $0.04B | 45.36% |
| 2010-09-30 | $0.09B | $0.04B | 41.57% |
| 2010-06-30 | $0.08B | $0.03B | 37.35% |
| 2010-03-31 | $0.08B | $0.02B | 32.00% |
| 2009-12-31 | $0.07B | $0.02B | 27.27% |
| 2009-09-30 | $0.06B | $0.01B | 20.69% |
| 2009-06-30 | $0.05B | $0.01B | 12.24% |
| 2009-03-31 | $0.04B | $0.00B | 2.44% |
| 2008-12-31 | $0.04B | $0.00B | -11.11% |
| 2008-09-30 | $0.03B | $-0.01B | -25.00% |
| 2008-06-30 | $0.02B | $-0.01B | -50.00% |
| 2008-03-31 | $0.02B | $-0.01B | -72.22% |
| 2007-12-31 | $0.01B | $-0.01B | -100.00% |
| 2007-09-30 | $0.01B | $-0.01B | -118.18% |
| 2007-06-30 | $0.01B | $-0.01B | -150.00% |
| 2007-03-31 | $0.01B | $-0.01B | -200.00% |
| 2006-12-31 | $0.00B | $-0.01B | -300.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $13.640B | $2.708B |
| Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $174.688B | 19.48 |
| Stryker (SYK) | United States | $129.889B | 24.88 |
| Medtronic (MDT) | Ireland | $111.968B | 15.57 |
| EssilorLuxottica (ESLOY) | France | $107.724B | 0.00 |
| Boston Scientific (BSX) | United States | $91.831B | 20.26 |
| Medline (MDLN) | United States | $59.904B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.712B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $33.391B | 15.98 |
| ResMed (RMD) | United States | $33.341B | 22.26 |
| Agilent Technologies (A) | United States | $32.516B | 20.44 |
| Koninklijke Philips (PHG) | Netherlands | $27.260B | 16.18 |
| Terumo (TRUMY) | Japan | $19.854B | 23.21 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.025B | 11.36 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.227B | 0.00 |
| Baxter (BAX) | United States | $8.854B | 7.56 |
| Sunny Optical Technology (SNPTF) | China | $8.381B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.537B | 28.15 |
| Demant (WILYY) | Denmark | $6.395B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $5.247B | 15.90 |
| Envista Holdings (NVST) | United States | $4.301B | 21.99 |
| BillionToOne (BLLN) | United States | $3.729B | 0.00 |
| DiaSorin S.p.A (DSRLF) | Italy | $3.666B | 0.00 |
| ICU Medical (ICUI) | United States | $3.141B | 20.47 |
| Prestige Consumer Healthcare (PBH) | United States | $2.676B | 12.62 |
| Haemonetics (HAE) | United States | $2.664B | 11.65 |
| LeMaitre Vascular (LMAT) | United States | $2.611B | 48.16 |
| Phibro Animal Health (PAHC) | United States | $2.347B | 20.67 |
| GN Store Nord (GNNDY) | Denmark | $2.270B | 21.90 |
| Neogen (NEOG) | United States | $2.050B | 44.86 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $2.028B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $1.794B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.654B | 32.89 |
| Curaleaf Holdings (CURLF) | Canada | $1.584B | 0.00 |
| Perrigo (PRGO) | Ireland | $1.495B | 3.96 |
| AtriCure (ATRC) | United States | $1.429B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.386B | 15.91 |
| Kestra Medical Technologies (KMTS) | United States | $1.043B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.953B | 164.50 |
| QuidelOrtho (QDEL) | United States | $0.943B | 6.53 |
| Lumexa Imaging Holdings (LMRI) | United States | $0.896B | 0.00 |
| InMode (INMD) | Israel | $0.857B | 9.40 |
| Omeros (OMER) | United States | $0.827B | 6.49 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.789B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.766B | 0.00 |
| CeriBell (CBLL) | United States | $0.683B | 0.00 |
| Brainsway (BWAY) | Israel | $0.546B | 55.68 |
| Valneva SE (VALN) | France | $0.532B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.468B | 11.18 |
| Cresco Labs (CRLBF) | United States | $0.458B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.424B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.415B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.367B | 25.70 |
| SNDL (SNDL) | Canada | $0.366B | 0.00 |
| Cerus (CERS) | United States | $0.363B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.311B | 126.00 |
| Evolus (EOLS) | United States | $0.278B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.259B | 0.00 |
| MacroGenics (MGNX) | United States | $0.229B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Accendra Health (ACH) | United States | $0.215B | 2.96 |
| Utah Medical Products (UTMD) | United States | $0.210B | 18.94 |
| High Tide (HITI) | Canada | $0.205B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.205B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.194B | 57.17 |
| TerrAscend (TSNDF) | Canada | $0.193B | 0.00 |
| Organigram Global (OGI) | Canada | $0.191B | 0.00 |
| Apyx Medical (APYX) | United States | $0.166B | 0.00 |
| Quanterix (QTRX) | United States | $0.158B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.152B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.145B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.143B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.133B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.53 |
| Jushi Holdings (JUSHF) | United States | $0.101B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.090B | 11.73 |
| Exagen (XGN) | United States | $0.073B | 0.00 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| ImmuCell (ICCC) | United States | $0.064B | 0.00 |
| Biote (BTMD) | United States | $0.063B | 3.46 |
| INLIF (INLF) | China | $0.053B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.038B | 0.00 |
| Veru (VERU) | United States | $0.038B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| Nephros (NEPH) | United States | $0.032B | 26.91 |
| United-Guardian (UG) | United States | $0.030B | 14.23 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Jin Medical (ZJYL) | China | $0.018B | 0.00 |
| Modular Medical (MODD) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Agape ATP (ATPC) | $0.003B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.001B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |